TANYA LAMBRIGHT: Open Payments
NPI 1801306592 · DAVENPORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,785 in 104 payments from 30 companies in 2025. Trend: 2023 $3,616 · 2024 $3,469 · 2025 $2,785
Food & beverage: $2,785
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $345 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $229 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $202 |
| Novartis Pharmaceuticals Corporation | 8 | $196 |
| GENZYME CORPORATION | 4 | $180 |
| AstraZeneca Pharmaceuticals LP | 8 | $172 |
| ABBVIE INC. | 7 | $160 |
| Merck Sharp & Dohme LLC | 7 | $156 |
| CVRx, Inc. | 1 | $156 |
| Celgene Corporation | 3 | $106 |
Products named: Nubeqa, Barostim Neo System, RYBREVANT, TECVAYLI, KEYTRUDA, OFEV, REBLOZYL, JARDIANCE.
Industry payments across FL — which companies pay providers there.
